Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

China

- PMLiVE

GSK set ‘to cut 1,000 jobs’ in China

Pharma company's troubles in the country reportedly continue

- PMLiVE

Boehringer drug approved in EU for rare lung disease

Nintedanib is already available as cancer treatment

China flag thumb

China approves home-grown polio vaccine

Country clamps down on recent outbreaks of disease

Shire Basingstoke

Shire signs deal to buy NPS for $5.2bn

Firm hopes to boost its presence in rare disease sector

- PMLiVE

Type 2 diabetes market in Asia-Pacific to hit $10.5bn by 2020

Analysts predict increase of $4bn from 2013 figure

- PMLiVE

Assessing drugs for ultra-rare conditions in the UK

Alexion’s Soliris has become the first drug to pass through NICE’s new highly specialised technology process

Bristol-Myers Squibb (BMS) building

BMS to fund hepatitis projects in China and India

Pharma firm awards nine grants to support care for high-risk patients

- PMLiVE

MRC Technology and Yabao form Parkinson’s partnership in China

Companies will target specific kinase involved in neurodegeneration

- PMLiVE

Extra stomach cancer indication for Cyramza in US

FDA backs Lilly drug in combination with paclitaxel chemotherapy

- PMLiVE

Vertex submits Kalydeco combo for cystic fibrosis

Seeks approval in both US and Europe

Bayer symbol

Bayer completes takeover of Chinese OTC company

Expands consumer health presence with Dihon purchase

- PMLiVE

Orphan drug market to reach $176bn by 2020

New report suggests market will almost double in five years

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links